Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C8F18O2S |
| Molecular Weight | 502.121 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)S(F)(=O)=O
InChI
InChIKey=BHFJBHMTEDLICO-UHFFFAOYSA-N
InChI=1S/C8F18O2S/c9-1(10,3(13,14)5(17,18)7(21,22)23)2(11,12)4(15,16)6(19,20)8(24,25)29(26,27)28
| Molecular Formula | C8F18O2S |
| Molecular Weight | 502.121 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. | 2003 Aug |
|
| Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility. | 2003 Oct |
|
| An occupational exposure assessment of a perfluorooctanesulfonyl fluoride production site: biomonitoring. | 2003 Sep-Oct |
|
| Analysis of episodes of care in a perfluorooctanesulfonyl fluoride production facility. | 2004 Aug |
|
| Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. | 2004 Aug |
|
| Historical comparison of perfluorooctanesulfonate, perfluorooctanoate, and other fluorochemicals in human blood. | 2005 May |
|
| Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat. | 2005 Oct |
|
| The applicability of biomonitoring data for perfluorooctanesulfonate to the environmental public health continuum. | 2006 Nov |
|
| The use of biomonitoring data in exposure and human health risk assessments. | 2006 Nov |
|
| Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden. | 2007 Feb |
|
| Differences in the isomer composition of perfluoroctanesulfonyl (PFOS) derivatives. | 2007 Feb 15 |
|
| Rapid response of Arctic ringed seals to changes in perfluoroalkyl production. | 2007 Jan 1 |
|
| Self-reported medical conditions in perfluorooctanesulfonyl fluoride manufacturing workers. | 2007 Jul |
|
| Bladder cancer in perfluorooctanesulfonyl fluoride manufacturing workers. | 2007 Jun |
|
| Preliminary evidence of a decline in perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations in American Red Cross blood donors. | 2007 May |
|
| Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. | 2007 Nov |
|
| Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. | 2007 Nov |
|
| Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. | 2007 Nov |
|
| Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006. | 2008 Jul 1 |
|
| Developmental neurotoxicity of perfluorinated chemicals modeled in vitro. | 2008 Jun |
|
| Prenatal exposure to perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) and maternally reported developmental milestones in infancy. | 2008 Oct |
|
| Dietary predictors and plasma concentrations of perfluorinated compounds in a coastal population from northern Norway. | 2009 |
|
| Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. | 2009 Apr |
|
| Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adults. | 2009 Apr |
|
| Modeling the global fate and transport of perfluorooctane sulfonate (PFOS) and precursor compounds in relation to temporal trends in wildlife exposure. | 2009 Dec 15 |
|
| A comparison of the pharmacokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, and humans. | 2009 Feb 4 |
|
| A first global production, emission, and environmental inventory for perfluorooctane sulfonate. | 2009 Jan 15 |
|
| Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. | 2010 May |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:47:21 GMT 2023
by
admin
on
Fri Dec 15 17:47:21 GMT 2023
|
| Record UNII |
KPV81L86O0
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
307-35-7
Created by
admin on Fri Dec 15 17:47:21 GMT 2023 , Edited by admin on Fri Dec 15 17:47:21 GMT 2023
|
PRIMARY | |||
|
KPV81L86O0
Created by
admin on Fri Dec 15 17:47:21 GMT 2023 , Edited by admin on Fri Dec 15 17:47:21 GMT 2023
|
PRIMARY | |||
|
206-200-6
Created by
admin on Fri Dec 15 17:47:21 GMT 2023 , Edited by admin on Fri Dec 15 17:47:21 GMT 2023
|
PRIMARY | |||
|
DTXSID5027140
Created by
admin on Fri Dec 15 17:47:21 GMT 2023 , Edited by admin on Fri Dec 15 17:47:21 GMT 2023
|
PRIMARY | |||
|
Perfluorooctanesulfonyl fluoride
Created by
admin on Fri Dec 15 17:47:21 GMT 2023 , Edited by admin on Fri Dec 15 17:47:21 GMT 2023
|
PRIMARY | |||
|
5561
Created by
admin on Fri Dec 15 17:47:21 GMT 2023 , Edited by admin on Fri Dec 15 17:47:21 GMT 2023
|
PRIMARY | |||
|
9388
Created by
admin on Fri Dec 15 17:47:21 GMT 2023 , Edited by admin on Fri Dec 15 17:47:21 GMT 2023
|
PRIMARY |